Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05935267 · ClinicalTrials.gov registry record
Thoracostomy Tube Irrigation: a Multi-Center Trial
A clinical trial of Thoracic Trauma, sponsored by Methodist Health System.
- Active
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT05935267: Active study of Thoracic Trauma, sponsored by Methodist Health System.
NCT05935267 is a study of Thoracic Trauma that is active but no longer recruiting, run by Methodist Health System. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05935267, a study of Thoracic Trauma, is active but no longer recruiting, sponsored by Methodist Health System.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
All trauma patients ages 18 years or older presenting within 24 hours of blunt or penetrating injury resulting in traumatic HTx or HPTx will be eligible for enrollment. This prospective comparative study will consist of a non-irrigation control arm and a thoracic irrigation experimental arm. Thoracic irrigation is performed at the time of the initial TT placement, and is done at the discretion of the attending Trauma surgeon. All patients enrolled will be entered in a prospectively maintained thoracic trauma database. The primary outcome is need for secondary intervention, defined as additional TT placement, VATS, tissue plasminogen activator (tPA), or thoracotomy for the management of retained HTx. Secondary interventions will be screened according to indication. Only secondary interventions directed at management of retained collection will be considered in the analysis for our primary outcome. Secondary intervention aimed at persistent air leaks or post-pull PTx will be considered separately in any analysis.
Primary Outcome
thoracic trauma resulting in the formation of pneumothorax (PTx), hemothorax (HTx), or hemopneumothorax (HPTx) is successfully managed with thoracostomy tube (TT) placement to evacuate blood and / or air from the pleural space.
Conditions Studied
Interventions
- PROCEDURE thoracic irrigation
Study Locations (1)
Texas
- Clinical Research Institute Methodist Health System - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2021-12-30 |
| Est. Completion | 2024-12-31 |
What the registry record for NCT05935267 still lists
NCT05935267 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Thoracic Trauma appearing as the primary indexed condition, and to 1 intervention - of which thoracic irrigation is the first listed.
NCT05935267 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05935267 about?
NCT05935267 is a clinical study titled "Thoracostomy Tube Irrigation: a Multi-Center Trial". All trauma patients ages 18 years or older presenting within 24 hours of blunt or penetrating injury resulting in traumatic HTx or HPTx will be eligible for enrollment. This prospective comparative study will consist of a non-irrigation control arm and a thoracic irrigation experimental arm. Thoraci...
What is the current status of trial NCT05935267?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2021-12-30. Estimated completion is 2024-12-31.
What conditions does trial NCT05935267 study?
This clinical trial studies the following conditions: Thoracic Trauma.
What interventions are being tested in trial NCT05935267?
The interventions under investigation include: thoracic irrigation (PROCEDURE).
Who is sponsoring clinical trial NCT05935267?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05935267 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI